| NGL Group | GL Group | P-value |
---|---|---|---|
Parameter | n = 314 | n = 58 |  |
Recipient characteristics | |||
 Age (mean ± SD, years) | 36.39 ± 9.39 | 37.59 ± 10.79 | 0.383 |
 Male/female ratio | 220/94 | 50/8 | 0.118 |
 BMI (mean ± SD, kg/m2) | 20.83 ± 3.15 | 20.46 ± 3.69 | 0.427 |
ABO blood type (n,%) | |||
 A | 95 (30.3%) | 20 (35.1%) | 0.414 |
 B | 95 (30.3%) | 21 (36.8%) |  |
 AB | 25 (8.0%) | 4 (7.0%) |  |
 O | 99 (31.5%) | 12 (21.1%) |  |
 HLA mismatch (mean ± SD) | 1.82 ± 1.00 | 1.84 ± 1.06 | 0.984 |
  Dialysis | |||
 PD/HD ratio | 29/275 | 6/49 | 0.809 |
 time before Tx (mean ± SD, months) | 22.61 ± 21.83 | 21.98 ± 19.44 | 0.838 |
 PRA positive (n,%) | 24 (7.6%) | 8 (13.8%) | 0.201 |
Donor characteristics | |||
 Age (mean ± SD, years) | 40.18 ± 16.22 | 38.37 ± 19.09 | 0.804 |
 Male/female ratio | 145/36 | 24/7 | 0.918 |
 BMI (mean ± SD, kg/m2) | 21.76 ± 3.70 | 21.15 ± 3.44 | 0.594 |
Cause of death (n,%) | |||
 Trauma | 91 (50.0%) | 19 (61.3%) | 0.594 |
 Cerebrovascular disorders | 64 (35.2%) | 9 (29.0%) |  |
 Hypoxic ischemic encephalopathy | 13 (7.1%) | 2 (6.5%) |  |
 Tumor | 10 (5.5%) | 0 (0.0%) |  |
 Others | 4 (2.2%) | 1 (3.2%) |  |
 History of hypertension (n,%) | 42 (23.1%) | 8 (25.0%) | 0.992 |
 Terminal sCr (mean ± SD, μmol/L) | 107.99 ± 76.80 | 99.53 ± 66.50 | 0.565 |
Cold ischemia time (mean ± SD, hours) | 6.48 ± 3.00 | 6.01 ± 2.95 | 0.417 |
 Warm ischemia time (mean ± SD, mins) | 7.84 ± 3.88 | 8.74 ± 3.29 | 0.221 |
 ECD(n,%) | 29 (15.9%) | 8 (25.0%) | 0.319 |